![Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/LebwohlImage1May2020.jpg)
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis. - Document - Gale OneFile: Health and Medicine
![Figure 2 from Randomized Comparison of Topical Betamethasone Valerate Foam, Intralesional Triamcinolone Acetonide and Tacrolimus Ointment in Management of Localized Alopecia Areata | Semantic Scholar Figure 2 from Randomized Comparison of Topical Betamethasone Valerate Foam, Intralesional Triamcinolone Acetonide and Tacrolimus Ointment in Management of Localized Alopecia Areata | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4d5d0a378cada3d955adfcf5f143e6ab19fe697b/4-Figure2-1.png)
Figure 2 from Randomized Comparison of Topical Betamethasone Valerate Foam, Intralesional Triamcinolone Acetonide and Tacrolimus Ointment in Management of Localized Alopecia Areata | Semantic Scholar
![JCM | Free Full-Text | Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment JCM | Free Full-Text | Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment](https://www.mdpi.com/jcm/jcm-10-05589/article_deploy/html/images/jcm-10-05589-g001.png)